AB Science S.A. Profile Avatar - Palmy Investing

AB Science S.A.

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III cl…

Drug Manufacturers - Specialty & Generic
FR, Paris [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

AB Science S.A. has no acquisition track records yet.

M&A Deals · History

AB Science S.A. has no acquisition track records yet.

M&A Deals · Within Industry

No current deals within Drug Manufacturers - Specialty & Generic Industry.

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
Details
?
Equity
Agg. Maximum Price
$n/a
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
End of AB.PA's Analysis
CIK: - CUSIP: - ISIN: FR0010557264 LEI: - UEI: -
Secondary Listings
AB.PA has no secondary listings inside our databases.